Syngene International Ltd Faces Bearish Momentum Amid Technical Downgrade

Technical Trend Shift and Momentum Analysis

Syngene International’s technical trend has deteriorated from mildly bearish to outright bearish, reflecting increased selling pressure. The daily moving averages have turned decisively bearish, indicating that short-term price action is under strain. The stock closed at ₹398.85, down from the previous close of ₹413.65, with intraday lows touching ₹375.50, close to its 52-week low of ₹375.50. This proximity to the annual low highlights the stock’s vulnerability in the current market environment.

The Moving Average Convergence Divergence (MACD) presents a mixed picture. On a weekly basis, the MACD remains mildly bullish, suggesting some underlying positive momentum in the medium term. However, the monthly MACD is bearish, signalling that the longer-term trend is weakening. This divergence between weekly and monthly MACD readings points to a potential conflict between short-term recovery attempts and sustained downward pressure.

The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no clear signal, hovering in neutral territory. This lack of momentum confirmation from RSI suggests that the stock is neither oversold nor overbought, leaving room for further downside or sideways consolidation depending on broader market cues.

Bollinger Bands and KST Indicator Insights

Bollinger Bands on both weekly and monthly timeframes are bearish, indicating that price volatility is skewed towards the downside. The stock price is trading near the lower band, which often signals increased selling pressure and potential continuation of the downtrend. Meanwhile, the Know Sure Thing (KST) indicator shows a mildly bullish stance on the weekly chart but remains bearish on the monthly scale, reinforcing the notion of short-term attempts at recovery overshadowed by longer-term weakness.

Volume and Dow Theory Confirmation

On-Balance Volume (OBV) analysis reveals no clear trend on the weekly chart, but a bullish trend on the monthly chart. This suggests that while recent trading volumes have not decisively supported price moves, longer-term accumulation may be occurring. However, Dow Theory assessments on both weekly and monthly charts remain mildly bearish, confirming the prevailing negative sentiment among market participants.

Comparative Performance Against Sensex

Syngene International’s price performance has lagged significantly behind the benchmark Sensex across multiple time horizons. Over the past week, the stock declined by 1.02% while the Sensex gained 2.01%. The one-month return for Syngene was a steep -9.27%, contrasting with the Sensex’s positive 1.90%. Year-to-date, Syngene has plummeted 38.72%, far underperforming the Sensex’s -8.56% decline. Over one year, the stock’s return was -44.77% versus the Sensex’s -4.36%, and over three and five years, Syngene’s cumulative losses of 51.64% and 37.62% starkly contrast with the Sensex’s gains of 17.79% and 48.19%, respectively. Even over a decade, Syngene’s 90.86% gain trails the Sensex’s robust 177.80% appreciation.

Mojo Score and Market Sentiment

MarketsMOJO has downgraded Syngene International Ltd’s Mojo Grade from Sell to Strong Sell as of 30 July 2026, reflecting a deteriorating outlook. The current Mojo Score stands at a low 19.0, signalling weak fundamentals and technicals. This downgrade aligns with the bearish technical indicators and the stock’s underperformance relative to the broader market.

As a small-cap stock in the Healthcare Services sector, Syngene faces heightened volatility and sensitivity to sector-specific developments. The bearish daily moving averages and negative price momentum suggest that investors are increasingly cautious, possibly awaiting clearer signs of recovery or sector tailwinds.

Key Technical Levels and Outlook

With the stock trading near its 52-week low of ₹375.50 and well below its 52-week high of ₹728.40, the risk-reward profile appears skewed towards further downside in the near term. The lack of RSI signals and mixed MACD readings imply that a sustained reversal is not imminent without a catalyst. Investors should monitor the daily moving averages closely, as a continued bearish stance there could reinforce downward momentum.

Volume trends, as indicated by OBV, suggest some longer-term accumulation, but this has yet to translate into price strength. The mildly bullish weekly KST and MACD readings offer a glimmer of hope for short-term relief rallies, but these are overshadowed by the monthly bearish signals and Dow Theory confirmations.

Investor Considerations and Final Assessment

Given the current technical landscape, Syngene International Ltd remains a challenging proposition for investors seeking momentum or stability. The Strong Sell rating from MarketsMOJO, combined with bearish moving averages and Bollinger Bands, suggests that caution is warranted. The stock’s persistent underperformance against the Sensex over multiple time frames further emphasises the need for careful risk management.

Investors should watch for any shifts in monthly MACD and Dow Theory signals, which could herald a longer-term trend reversal. Until then, the prevailing technical indicators point to continued downside risk or sideways consolidation. Those holding the stock may consider evaluating peer alternatives within the Healthcare Services sector or broader market, as highlighted by comparative tools.

In summary, Syngene International Ltd’s technical parameters reveal a stock grappling with bearish momentum and mixed signals. While short-term indicators offer some mild bullish hints, the dominant monthly trends and volume patterns caution against aggressive positioning. A prudent approach would be to monitor technical developments closely and consider diversification to mitigate downside exposure.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →